May 20, 2026 Critical Path Institute Awards $249,719 Grant to Odylia Therapeutics to Advance Gene Therapy for USH1C-Associated Vision Loss TUCSON, Ariz., May 20, 2026 — Critical Path Institute® (C-Path) today announced the award of a $249,719 research grant...
May 19, 2026 Critical Path Institute Launches New Approach Methodologies Developer Coalition to Advance Human-Relevant Tools for Drug Development TUCSON, Ariz., and AMSTERDAM, May 19, 2026 — Critical Path Institute® (C-Path) today announced the launch of the New...
April 28, 2026 Critical Path Institute Awards $456,000 Grant to Advance Next-Generation Therapy for Rare Glycolipid Storage Disorders TUCSON, Ariz., April 28, 2026 — Critical Path Institute® (C-Path) today announced a $456,000 grant to James Shayman...
April 22, 2026 AIRNA Joins C-Path’s Alpha-1 Antitrypsin Deficiency Consortium to Advance Innovative AATD Treatments TUCSON, Ariz., April 22, 2026 — Critical Path Institute’s® (C-Path) Critical Path for Alpha-1 Antitrypsin...
April 8, 2026 C-Path’s Translational Therapeutics Accelerator Awards $501,000 Grant to Advance Novel Treatment for Cryptosporidiosis in Children TUCSON, Ariz., April 8, 2026 — Critical Path Institute’s® (C-Path) Translational Therapeutics Accelerator has awarded...
March 26, 2026 Critical Path Institute Launches ‘One to Millions’ to Reshape the Future of Individualized Medicine at Global Scale C-Path today announced the launch of One to Millions, a global, multi-stakeholder public-private initiative...
March 23, 2026 Critical Path Institute and Collaborators Honored with Society of Toxicology Science Paper of the Year Award TUCSON, Ariz., March 23, 2026 — Critical Path Institute® (C-Path) announced today that the Society of Toxicology (SOT)...
March 17, 2026 PBC Ireland Partners with C-Path’s Rare Disease Data Platform, Advancing Research Efforts for Primary Biliary Cholangitis TUCSON, Ariz., March 12, 2026 — In a significant step to enhance research efforts for Primary Biliary Cholangitis...
March 10, 2026 New Study on Early Parkinson’s Disease Progression Highlights Vital Role of Patient Focused Drug Development and Real-World Impacts TUCSON, Ariz., March 5, 2026 – Critical Path Institute® (C-Path) applauds the publication of a new study in the Journal of...
March 3, 2026 Critical Path Institute’s Translational Therapeutics Accelerator Awards Grant to Support Development of Novel Nonopioid Pain Therapeutics TUCSON, Ariz., March 3, 2026 — Critical Path Institute’s® (C-Path) Bridging Research and Innovation in Drug Development...